Dr. Lawrence Fong

Dr. Lawrence Fong, MD, is a leading figure in the field of cancer immunotherapy, renowned for his groundbreaking work in harnessing the immune system to fight cancer. He is a Professor of Medicine at the University of California, San Francisco (UCSF), where he holds the Efim Guzik Distinguished Professorship in Cancer Biology and leads the Cancer Immunotherapy Program. A board-certified medical oncologist, Dr. Fong earned his medical degree from Stanford University and completed his residency and fellowship training at UCSF. His career has been defined by a commitment to translating scientific discovery into transformative treatments for patients.

Dr. Fong is internationally known for his pioneering contributions to cancer vaccine and checkpoint blockade therapy development. His research focuses on understanding the mechanisms that determine whether immunotherapy will be effective for individual patients, with an emphasis on prostate, bladder, and kidney cancers. He has played a critical role in early-phase clinical trials and biomarker discovery, helping to establish foundational strategies that inform immunotherapy treatment protocols. His work is extensively published in leading scientific journals and has been integral to shaping the future of precision immuno-oncology.

In addition to his clinical and research achievements, Dr. Fong is a dedicated mentor and educator, training the next generation of physician-scientists in cancer immunotherapy. He is a frequent speaker at international oncology conferences and serves on advisory boards for major cancer research initiatives. Through his relentless pursuit of innovation and patient-centered research, Dr. Fong has helped redefine the landscape of cancer treatment, offering new hope through immune-based therapies that are changing lives worldwide.